Pharmicell signs ₩7.4bn electronic materials supply contract with Doosan
Pharmicell disclosed a supply contract for electronic materials with counterparty Doosan Corporation, which the filing reports as 6.5% of revenue. The contract amount is ₩7.4bn, with a period from Oct 13, 2026 to Dec 31, 2026.
Key facts
| Contract name | Electronic materials supply contract |
|---|---|
| Counterparty | Doosan Corporation |
| Contract amount | ₩7.4bn |
| % of revenue (as reported) | 6.5% |
| Period start | Oct 13, 2026 |
| Period end | Dec 31, 2026 |
Comparison
| Amount as % of FY2025 revenue (calculated) | 6.5% |
|---|---|
| Revenue 2025 | ₩114.1bn |
| Revenue 2024 | ₩64.9bn |
| Revenue 2023 | ₩56.2bn |
Context
In the 12 months before this filing, Pharmicell filed 5 supply contracts totaling ₩36.3bn, and 1 of them was with this counterparty.
Key metrics
Supply contracts
| Supply contracts, last 12 months | ₩39.6bn |
|---|---|
| Supply contracts vs prior-year revenue | 34.7% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Source: DART (Financial Supervisory Service) · Original filing on DART ↗